Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on April 2, 2025

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire

a day ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Argus Research

7 days ago

ANIP: Raising target price to $70.00

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Zacks

8 days ago

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

8 days ago

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Zacks

8 days ago

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Zacks

8 days ago

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

Zacks

11 days ago

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

MT Newswires

13 days ago

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

GlobeNewswire

14 days ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

14 days ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

MT Newswires

15 days ago

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

GlobeNewswire

15 days ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

15 days ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

MT Newswires

19 days ago

ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien

MT Newswires

19 days ago

Jefferies Initiates Coverage on ANI Pharmaceuticals With Buy Rating, $80 Price Target

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

GlobeNewswire

19 days ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Zacks

20 days ago

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

20 days ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks

20 days ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

Zacks

21 days ago

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

1 Growth Stock to Target This Week and 2 to Avoid

StockStory

21 days ago

1 Growth Stock to Target This Week and 2 to Avoid

MT Newswires

21 days ago

JPMorgan Initiates ANI Pharmaceuticals at Overweight With $85 Price Target

MT Newswires

25 days ago

Ani Pharmaceuticals Insider Sold Shares Worth $323,049, According to a Recent SEC Filing

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

Zacks

25 days ago

Wall Street Analysts Believe ANI (ANIP) Could Rally 32.4%: Here's is How to Trade

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

a month ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Zacks

a month ago

ANI (ANIP) Upgraded to Strong Buy: Here's What You Should Know

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

a month ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Zacks

a month ago

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

a month ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Argus Research

a month ago

ANIP: Raising target price to $47.00

ANI Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

ANI Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

MT Newswires

a month ago

ANI Pharmaceuticals Gets FDA Approval for Cortrophin Gel in Prefilled Syringe Format as MS Therapy

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

GlobeNewswire

a month ago

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

Thomson Reuters StreetEvents

a month ago

Q4 2024 ANI Pharmaceuticals Inc Earnings Call

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today

StockStory

a month ago

Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Friday Afternoon

ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a month ago

ANI (ANIP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

MT Newswires

a month ago

Sector Update: Health Care Stocks Steady Pre-Bell Friday

MT Newswires

a month ago

Sector Update: Health Care

Associated Press Finance

a month ago

ANI: Q4 Earnings Snapshot

MT Newswires

a month ago

ANI Pharmaceuticals' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Outlook

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars

StockStory

a month ago

ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

GlobeNewswire

a month ago

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q4 2024: Everything You Need To Know Ahead Of Earnings

Argus Research

a month ago

ANIP: Lowering target price to $44.00

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory

a month ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

GlobeNewswire

a month ago

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory

a month ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

Argus Research

a month ago

ANIP: Lowering target price to $47.00

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

GlobeNewswire

a month ago

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

a month ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks

a month ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?

Zacks

a month ago

Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory

2 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory

2 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Argus Research

2 months ago

ANIP: What does Argus have to say about ANIP?

Is ANI Pharmaceuticals (ANIP) Stock Undervalued Right Now?

Zacks

2 months ago

Is ANI Pharmaceuticals (ANIP) Stock Undervalued Right Now?

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Zacks

2 months ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 53% gain

Simply Wall St.

2 months ago

Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 53% gain

Argus Research

2 months ago

ANIP: What does Argus have to say about ANIP?

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

Argus Research

2 months ago

ANIP: Rating decreased to a SELL

Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?

Zacks

3 months ago

Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?

Argus Research

3 months ago

ANIP: What does Argus have to say about ANIP?

Alcami Announces CEO Transition

PR Newswire

3 months ago

Alcami Announces CEO Transition

MT Newswires

3 months ago

Ani Pharmaceuticals Sees Fiscal 2024 Adjusted EPS, Revenue at or Above Guidance; Sets Fiscal 2025 Revenue Outlook

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

GlobeNewswire

3 months ago

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Thursday

MT Newswires

3 months ago

ANI Pharmaceuticals Launches Generic Version of Motegrity

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Zacks

3 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

3 months ago

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

All You Need to Know About ANI (ANIP) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About ANI (ANIP) Rating Upgrade to Buy

Argus Research

3 months ago

ANIP: Lowering target price to $57.00

MT Newswires

3 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $418,425, According to a Recent SEC Filing

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

3 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Argus Research

3 months ago

ANIP: Lowering target price to $59.00

MT Newswires

4 months ago

Leerink Partners Initiates ANI Pharmaceuticals at Outperform With $80 Price Target

Argus Research

4 months ago

ANIP: Raising target price to $62.00

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Argus Research

4 months ago

ANIP: Lowering target price to $60.00

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

4 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

MT Newswires

4 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing

Argus Research

4 months ago

ANIP: Raising target price to $61.00

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

GlobeNewswire

4 months ago

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

Zacks

4 months ago

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

4 months ago

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

4 months ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

MT Newswires

4 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $375,050, According to a Recent SEC Filing

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

5 months ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Argus Research

5 months ago

ANIP: Raising target price to $64.00

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

5 months ago

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

5 months ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

Zacks

5 months ago

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

Zacks

5 months ago

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

MT Newswires

5 months ago

ANI Pharmaceuticals' Q3 Adjusted Earnings, Net Revenue Rise; Fiscal 2024 Outlook Lifted

Associated Press Finance

5 months ago

ANI: Q3 Earnings Snapshot

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire

5 months ago

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

5 months ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

Share on Social Networks: